[Assessment of goserelin treatment in adjuvant therapy for premenopausal patients with breast cancer in Japan-zoladex breast cancer study group trial-B].

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Goserelin (GOS) therapy in an adjuvant setting for estrogen receptor(ER)-positive premenopausal patients with breast cancer was assessed in a randomised comparative study.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Gan To Kagaku Ryoho

Title: Gan to kagaku ryoho. Cancer & chemotherapy

ISSN: 0385-0684

ISSN (Print): 0385-0684

Publication date (Electronic): Dec 2005

Volume: 32

Issue: 13

Affiliations

[1 ] Dept. of Surgery, Kitakyushu Municipal Medical Center.

Article

PubMed ID: 16352931

SO-VID: 148fb115-157a-4d31-8176-919e430e2d2b

History

Data availability:

Comments

Comment on this article

Cited by 1

Tamoxifen with ovarian function suppression versus tamoxifen alone as an adjuvant treatment for premenopausal breast cancer: a meta-analysis of published randomized controlled trials
Authors: Shunchao Yan, Kai Li, Xin Jiao …

See all cited by